Skip to content
Screener

Charles River Laboratories CRL Non-Controlling Interests

Non-Controlling Interests at other companies

IQVIA logo
IQVIAIQV
$130M+1,525%
Quest Diagnostics logo
Quest DiagnosticsDGX
$303M+719%
Danaher logo
DanaherDHR
$11M+37.5%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemJune 27, 2026December 27, 2025
Retained earnings1,372,2951,388,620
Treasury stock, at cost, 1,822 and zero shares, as of June 27, 2026 and December 27, 2025, respectively(323,189)
Accumulated other comprehensive loss(195,989)(171,783)
Total Charles River Laboratories International, Inc. equity2,839,6363,164,630
Nonredeemable noncontrolling interest6,3545,301
Total equity2,845,9903,169,931
Total liabilities, redeemable noncontrolling interests and equity$7,532,145$7,135,422
See Notes to Unaudited Condensed Consolidated Financial Statements.

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's non-controlling interests?
Charles River Laboratories (CRL) reported non-controlling interests of $6.35M in Q2 2026.
How has Charles River Laboratories's non-controlling interests changed year-over-year?
Charles River Laboratories's non-controlling interests increased by 0.7% year-over-year, from $6.31M to $6.35M.
What is the long-term trend for Charles River Laboratories's non-controlling interests?
Over 5 years (2020 to 2025), Charles River Laboratories's non-controlling interests has grown at a 8.2% compound annual growth rate (CAGR), from $3.57M to $5.3M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.

Ask your AI about Charles River Laboratories's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude